ARTICLE | Clinical News
Remune: Phase III trial update
March 29, 1999 8:00 AM UTC
The Immune Response Corp. (IMNR), Carlsbad, Calif. Product: Remune Business: Infectious diseases Therapeutic category: Immune stimulation Target: HIV core proteins Description: Inactivated gp120-deple...